NO990157L - Granulater av heksahydropyrazinderivater som kan bli administrert oralt - Google Patents

Granulater av heksahydropyrazinderivater som kan bli administrert oralt

Info

Publication number
NO990157L
NO990157L NO990157A NO990157A NO990157L NO 990157 L NO990157 L NO 990157L NO 990157 A NO990157 A NO 990157A NO 990157 A NO990157 A NO 990157A NO 990157 L NO990157 L NO 990157L
Authority
NO
Norway
Prior art keywords
granules
administered orally
hexahydropyrazine derivatives
hexahydropyrazine
derivatives
Prior art date
Application number
NO990157A
Other languages
English (en)
Other versions
NO990157D0 (no
NO325272B1 (no
Inventor
Jochen Kalbe
Terence Hopkins
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO990157D0 publication Critical patent/NO990157D0/no
Publication of NO990157L publication Critical patent/NO990157L/no
Publication of NO325272B1 publication Critical patent/NO325272B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO19990157A 1996-07-17 1999-01-14 Fremgangsmate for fremstilling av oralt administrerbare formuleringer av heksahydropyrazinderivater samt granulater inneholdende slike derivater NO325272B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19628776A DE19628776A1 (de) 1996-07-17 1996-07-17 Oral applizierbare Granulate von Hexahydropyrazinderivaten
PCT/EP1997/003537 WO1998003157A1 (de) 1996-07-17 1997-07-04 Oral applizierbare granulate von hexahydropyrazinderivaten

Publications (3)

Publication Number Publication Date
NO990157D0 NO990157D0 (no) 1999-01-14
NO990157L true NO990157L (no) 1999-01-14
NO325272B1 NO325272B1 (no) 2008-03-17

Family

ID=7800044

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19990157A NO325272B1 (no) 1996-07-17 1999-01-14 Fremgangsmate for fremstilling av oralt administrerbare formuleringer av heksahydropyrazinderivater samt granulater inneholdende slike derivater

Country Status (17)

Country Link
US (1) US6503536B2 (no)
EP (1) EP0912167B1 (no)
JP (1) JP4202422B2 (no)
KR (1) KR100485149B1 (no)
CN (1) CN1225579A (no)
AT (1) ATE227565T1 (no)
AU (1) AU711705B2 (no)
BR (1) BR9710377B1 (no)
CA (1) CA2260889C (no)
DE (2) DE19628776A1 (no)
DK (1) DK0912167T3 (no)
ES (1) ES2183200T3 (no)
HU (1) HUP9903180A3 (no)
NO (1) NO325272B1 (no)
NZ (1) NZ333745A (no)
PT (1) PT912167E (no)
WO (1) WO1998003157A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4603357B2 (ja) * 2002-08-13 2010-12-22 インターベツト・インターナシヨナル・ベー・ベー 添加剤をデリバリーするための組成物及び方法
US20040180034A1 (en) * 2003-03-10 2004-09-16 Lyn Hughes Anthelmintic resinates and a method for their preparation
US7396819B2 (en) * 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
DE10358525A1 (de) 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
WO2005094210A2 (en) * 2004-03-12 2005-10-13 The Hartz Mountain Corporation Multi-action anthelmintic formulations
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
DE102007026550A1 (de) 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudate mit verbesserter Geschmacksmaskierung
US9233100B2 (en) 2012-02-06 2016-01-12 Merial, Inc. Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof
AU2013245011B2 (en) 2012-04-04 2017-11-23 Intervet International B.V. Solid oral pharmaceutical compositions for isoxazoline compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2362539C2 (de) 1973-12-17 1986-05-07 Merck Patent Gmbh, 6100 Darmstadt 2-Acyl-4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isochinoline, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US4447414A (en) * 1982-12-21 1984-05-08 Cutter Laboratories, Inc. Carnivore anthelmintics
DE3472678D1 (de) 1983-07-18 1988-08-18 Beecham Group Plc Benzazepine and benzoxazepine derivatives
DE3623321A1 (de) * 1986-07-11 1988-01-21 Bayer Ag Verfahren zur kontinuierlichen herstellung von sphaerischen granulaten
FI101344B1 (fi) * 1988-03-31 1998-06-15 Tanabe Seiyaku Co Menetelmä valmistaa valmiste, josta kontrolloidusti vapautuu farmaseuttisesti aktiivista ainetta
CN1099973A (zh) * 1993-09-08 1995-03-15 四川省医学科学院寄生虫病防治研究所 兽用驱虫药物复方制剂
AUPM969994A0 (en) 1994-11-28 1994-12-22 Virbac S.A. Equine anthelmintic formulations

Also Published As

Publication number Publication date
WO1998003157A1 (de) 1998-01-29
DK0912167T3 (da) 2003-03-10
KR20000067862A (ko) 2000-11-25
ES2183200T3 (es) 2003-03-16
KR100485149B1 (ko) 2005-04-25
NO990157D0 (no) 1999-01-14
PT912167E (pt) 2003-03-31
BR9710377A (pt) 1999-08-17
AU711705B2 (en) 1999-10-21
HUP9903180A3 (en) 2000-07-28
CA2260889C (en) 2007-09-11
JP2000515519A (ja) 2000-11-21
DE19628776A1 (de) 1998-01-22
ATE227565T1 (de) 2002-11-15
HUP9903180A2 (hu) 2000-04-28
US6503536B2 (en) 2003-01-07
CN1225579A (zh) 1999-08-11
CA2260889A1 (en) 1998-01-29
US20010055598A1 (en) 2001-12-27
NZ333745A (en) 2000-10-27
EP0912167A1 (de) 1999-05-06
DE59708723D1 (de) 2002-12-19
BR9710377B1 (pt) 2011-10-18
NO325272B1 (no) 2008-03-17
AU3541397A (en) 1998-02-10
EP0912167B1 (de) 2002-11-13
JP4202422B2 (ja) 2008-12-24

Similar Documents

Publication Publication Date Title
EA199900647A1 (ru) Фармацевтический препарат, включающий в себя амоксициллин и клавуланат
EP1283054A4 (en) MEDICAMENTS FOR TREATING THE COMPLICATIONS OF DIABETES AND NEUROPATHIES AND USE THEREOF
ES2160577T3 (es) Nuevos esteres de aminoalcoholes biciclicos y triciclicos, su preparacion y su utilizacion en medicamentos.
CA2258217A1 (en) Substituted cyclopentane compounds useful as neuraminidase inhibitors
NO990157L (no) Granulater av heksahydropyrazinderivater som kan bli administrert oralt
FI940696A (fi) Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö
MY117606A (en) Orally administrable formulations of quinolone- or naphthyridonecarboxylic acids
PT1091740E (pt) Preparacoes aquosas semi-solidas para administracao oral de toltrazuril-sulfona
CA2374471A1 (en) Therapeutically and/or nutritionally enhanced derivatives of active ingredients and orally administrable compositions containing same
HK1049326A1 (en) Non-hygroscopic salts of active ingredients havingtherapeutical and/or nutritional activities and o rally administrable compositions containing same.
JPS6456622A (en) Percutaneous absorbefacient base composition
KR910000645A (ko) 개선된 경련치료제
JPS5285179A (en) Preparation of carbamoylated 5-fluorouracils
JPS525769A (en) Preparation of 3-substituted pyrolidine derivatives
JPS5359095A (en) Preparation of 7-aminocephem cpds.
JPS5290694A (en) Preparation of protoporphyrine 1x
NO960271D0 (no) Tiokarbamoylforbindelser anvendt som mikrobiocider
TR200202281T2 (tr) Bileşim ve kullanım
RU96106995A (ru) Свечи с лидазой
FI930300A (fi) 5-Amino-1,2,4-tiadiatsol-3-yyli-iminokarbonyyliyhdiste
RU99118372A (ru) Антиоксидантная композиция
JPS5325558A (en) Novel pyrrole derivatives and their preparation
JPS5367795A (en) Preparation of microhydrogel
JPS5287183A (en) Derivatives of macrolide antibiotics
JPS52136149A (en) 3-epi-xk-88-5 as novel antibiotics and its preparation

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: BAYER INTELLECTUAL PROPERTY GMBH, DE

MM1K Lapsed by not paying the annual fees